City

Hong Kong (1)

Melbourne (1)

Condition

Acute Agitation (4)

Behavioural Emergency (1)

Overall Status

Completed (1)

Not yet recruiting (1)

Terminated (1)

Unknown status (1)

Sign in for free

Phase

n/a (1)

phase 1 (1)

phase 3 (1)

phase 4 (1)

Sponsor

Impel NeuroPharma Inc. (1)

Qilu Pharmaceutical Co., Ltd. (1)

St. Joseph's Healthcare Hamilton (1)

The University of Hong Kong (1)

Collaborator

Queen Elizabeth Hospital, Hong Kong (1)

Study Documents

Intervention Type

drug (3)

device (2)

behavioral (1)

Funder Type

Industry (2)

Other (2)

Study Type

Interventional (4)

acute agitation

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Acute Agitation Trial (Olanzapine, Haloperidol)

Not yet recruiting

Acute Agitation

(no location specified)

Mar 27, 2023

Acute Agitation, Behavioural Emergency Trial in Hong Kong (Olanzapine oro-dispersible 5Mg Tab, Haloperidol 2Mg encapsulated Tab,

Terminated

Acute Agitation
Behavioural Emergency

Olanzapine oro-dispersible 5Mg Tab
+2 more

Hong Kong, Hong Kong

Queen Elizabeth Hospital

Nov 3, 2022

Acute Agitation Trial in Melbourne (Zyprexa IM, Zydis, INP105)

Completed

Acute Agitation

Zyprexa IM
+3 more

Melbourne, Victoria, Australia

Nucleus Network Pty Ltd

Oct 3, 2018

Acute Agitation Trial (Pinel Restraints, Seclusion Room)

Unknown status

Acute Agitation

Pinel Restraints
Seclusion Room

(no location specified)

Jul 29, 2015